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Summary.-Previous studies ofnatural killer (NK) activity in the peripheral blood of
breast cancer patients have failed to show a reduction in cytotoxicity, an observation
at variance with results obtained in other malignancies. Interpretation of the
datahowever is complicated bythe presence oftreated andpost-mastectomypatients
in the groups studied.
In this study, lymphocytes from preoperative blood samples of untreated women
with benign and malignant breast disease were tested at various effector-to-target
ratios for cytotoxicity activity against the NK sensitive erythromyeloid cell line,
K562.
A significant reduction in NK activity was observed between carcinoma patients
and the control group (P=0.02). When the carcinoma group was further divided into
pre- and postmenopausal patients, the reduction was found to be a feature only of
premenopausal women (P=0.002). The levels of NK activity in patients with benign
breast disease were not significantly different from those in controls, irrespective of
menstrual status. There was no correlation between NK activity and tumour size,
oestrogen-receptor or lymph-node status in the carcinoma patients.
A preliminary analysis of NK activities in the control group suggests that women
donating blood in the first half of their menstrual cycle show significantly reduced
NK activity in comparison with those in the second half (P=0.001). This finding,
coupled with the variation in NK activity shown between pre- and postmenopausal
breast carcinoma patients, suggests that hormonal effects in conjunction with
malignancy determine the level of NK activity in breast cancer.
IT IS WELL ESTABLISHED that lympho-
cytes from unimmunized individuals are
capable of killing neoplastic cell lines in
vitro-the so-called natural killer (NK)
effect (Pross & Baines, 1977; Herberman &
Holden, 1978). Cytotoxicity occurs largely
independently of antibody (Trinchieri et
al., 1978), is potentiated by interferon
(Einhorn et al., 1978; Moore & Potter,
1980) andis claimed to be ofsignificance in
surveillance against spontaneously arising
tumours in man (Hersey et al., 1979) and
animals (Kiessling & Wigzell, 1979).
Indeed, in animal models the genetically
determined level ofNK activity influences
both the growth rate of tumour implants
(Kiessling & Wigzell, 1979) and outgrowth
ofexperimental metastases (Hanna, 1980).
Studies of NK activity of patients with
neoplastic diseases have shown a reduction
in comparison with control populations
and reduced activity is most clearly
displayed in individuals with advanced
neoplasia (Pross & Baines, 1976; Menon &
Stefani, 1978; Takasugi et al., 1977).
Women with breast cancer however have
not been shown to exhibit a reduced level
of NK activity, though the interpretation
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of the data is confused by the effects of
therapy and mastectomy (Cannon et al.,
1977; McCoy et al., 1973; Eremin et al.,
1978).
In this study NK activity has been
measured in a group of women donating
blood before initial breast biopsy, i.e.
before surgical or therapeutic interven-
tion. The breast disease present was
subsequently characterized histologically
as malignant or benign. The data pre-
sented suggest that hormonal factors may
be relevant to the levels of NK activity
observed in women with breast disease.
MATERIALS AND METHODS
Patients and controls.-Peripheral blood
mononuclear cells were prepared from hepar-
inized venous blood of 26 healthy female
controls and from 55 patients with clinically
palpable breast lumps. Details of menstrual
status and, in the case of patients, examina-
tion and clinical history, were noted at the
time of donation. Cytotoxic assays were
performed without knowledge of the histo-
logical diagnosis ofthe the breast lump. Table
I present details ofpatients and controls.
TABLE I.-Control and patient series
Volunteer controls
Breast carcinoma
Benign breast disease
No. Age range
26 21-82
23 34-76
32 19-62
Preparation of effector celts.-Effector cells
were prepared by centrifugation through
Ficoll-lriosil as previously described (Payne
etal., 1976; Serdengecti et at., 1981; aU culture
reagents were supplied by Gibco Biocult U.K.
Ltd (Paisley, Scotland). Briefly, venous blood
was mixed with an equal volume of calcium-
and magnesium-free Hanks' Balanced Salt
Solution (CMFHBS) and layered over Ficoll-
Triosil (Thorsby & Bratilie, 1970). Following
centrifugation at 400 g for 30 min, whole-
blood mononuclear cells were removed from
the gradient interface, washed x 3 in
CMFHBS and suspended at varying concen-
trations in complete medium RPMI 1640
supplemented with 10% fetal bovine serum
(SRPMI). Staining of mononuclear cell pre-
parations for x-naphthyl acetate esterase
(Yam et at., 1971) revealed 7-20% monocytes.
This figure did not vary significantly between
the groups studied.
Preparation of target cells.-The NK sensi-
tive erythromyeloid cell line K562 (Lozzio et
al., 1976) was maintained in serial culture in
SRPMI. Target cells were labelled by incuba-
ting for 45 min at 37°C with 100 IuCi of 51Cr
sodium chromate, (CJS4 Radiochemical
Centre, Amersham, U.K.), washed x 3 in
phosphate-buffered saline (PBS) suspended in
SRPMI and adjusted to a cell count of
5 x 104/ml.
Cytotoxicassay.-Aliquots (100IL) oftarget
cells were mixed with 100 1A of effector cell
suspensions in rigid "U"-bottomed poly-
styrene microtitre plates to give triplicate
effector:target (E:T) ratios from 80: 1 to
10: 1. The plates were centrifuged at 150 g for
5 min and incubated for 4 h at 37°C in an
atmosphere of5% CO2 in air.
After the incubation period the plates were
respun and lOO,u aliquots removed for y
counting. Values for spontaneous release were
obtained by target cells with medium alone
and for detergent release by incubating with
an equal volume of nonionic detergent. For
each E :T ratio studied the specific cytotox-
icitywas calculated fromthe mean ofeach set
oftriplicates by the formula
% specific cytotoxicity=
51Cr released by_51Cr released in
effectors medium
51Cr released in 51Cr released in
detergent medium
Control and patient groups were compared
using the two-sample t test.
RESULTS
Cytotoxicity in benign and malignant breast
disease
The values for cytotoxicity of26 normal
controls are shown in Fig. 1 and Table II.
In this system 51Cr release by normal
peripheral blood lympocytes rises linearly
with increasing E:T ratio to reach a
plateau at 80:1. An E:T ratio of 40:1,
representing a point on the ascending
linear portion of the cytotoxicity curve,
was therefore chosen to compare groups.
No difference was observedin NK levels in
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TABLE III.-Lack of correlation of NK
activity withprognosticfactors
Parameter
Lymph-node
involvement
Histological* grade
Lymphocystic
infiltrationt
Oestrogen-receptor
status§
No.
+ve 5 12-62+9-33
+ve 8 13-5+13-5
1 3 9-6+7-021
2 20 14-1+13-6
1 11 13-7+ 15-3
2 6 12-5+9*72
ER+ve 11 13-9+9-3
ER-ve 8 12-52+8-69
* Graded according to Histological Typing of
Breast Tumours No. 2 (1968), WHO, Geneva.
t Assessed histologically as density of infiltrate
under high power.
§ Measured by competitive binding.
t Small number of patients present in Group 1
prevents meaningful statistical analysis.
Control Premenopausal Post- Benign
patients Carcinoma ciienopausal breast
FiG. 1.-NK actil
and malignant
* Effector:targ
TABLE II.-Nal
trols and w(
measured agai,
Controls (all)
Premenopausal
Postmenopausal
Early breast
carcinoma (all)
Premenopausal
Postmenopausal
Benign breast
disease
* Mean of 3 value
t Significant diffi
by two-sample t tes
,nrp- nr -nntm
carcinoma disease divided into pre- and postmenopausal
vity in patients with benign women the significant difference is seen
breast disease and controls.
,et ration of 40: 1. only the premenopausal group
(P < 0-002); postmenopausal women with
tural killer activity of con- malignant breast disease have cytotoxici-
)men with breast disease ties which do not differ from those of
nst K562 targets volunteer controls (P o,0.05). The differ-
ence between healthy controls and
Mean % f patients with benign breast disease is not
No. cytotoxicity* cagcet significant (P 0.05). The number of
26 27yto7+x186 * n
postmenopausal patients with benign
17 272 +20-2 breast disease (indicated by triangular
9 28-5+16-2 - symbols in Fig. 1) was too small for
23 13-3 +13-0 <0-02 meaningful analysis. Cytotoxicity did not
13 9-1+8-1 <0-02 correlate with either the extent of the
10 18*9+16*3 >0°05 disease, patient's age or the oestrogen-
32 22_3+13-1 >0 05
receptor
status of the tumour (Table III).
Further, the peripheral blood cytotoxicity
3s at E:T ratio of 40:1 + 1. s.d. could not be related either to the grade of
erence from control clculated malignancy or to the degree of lympocyte
infiltration into the tumour assessed histo-
logically. pr-t;- Ur1 puJumILIUpOUus1 UIooUU iLonors
(Table II).
Values for the cytotoxicity observed
with whole peripheral blood mononuclear
cells from patients with subsequently
confirmed benign and malignant breast
disease are also shown in Fig. 1 and Table
II. Cytotoxicity directed to K562 targets
in patients with neoplastic disease is
significantly lower than the controls
(P < 0 02). When the carcinoma group is
The relation of mnenopausal status to
cytotoxicity
An interesting pattern emerged when
controls were grouped according to their
state in the menstrual cycle at time of
blood donation (Fig. 2). Seven women
tested in the second half of their cycle
showed specific cytotoxic activities of over
25%, while only 2/7 women tested in the
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Fi1G. 2.-NK activity of normal female voluii-
teers dividle(d betweeni first and(l sNcondl half
of menstrual cycle.
first half of their cycle exhibited cyto-
toxicity above this figure. The relationship
was not apparent in women taking hor-
monal contraceptives or women with
irregular cycles. The majority ofpremeno-
pausal carcinoma patients had irregular
cycles which prevented the detection of
cyclical variation in NK activity in this
group. The demands oftherapy prevented
further investigation of the carcinoma
group in this respect.
DISCUSSION
The results presented are generally
not in accord with previous studies of
periplheral blood NK activity of patients
with breast carcinoma, which claim levels
equivalent to those seen in control
populations. McCoy et al. (1973) showed
that of 24 women with breast cancer
none showed NK activity below 40o/% of
the control level. Other carcinoma
groups studied in the same paper (lung,
colon, lymphoma and melanoma) showed
a substantial number of patients with
activities below this level. Cannon et al.
(1977) measured the NK activity against
K562 of 35 women with breast cancer and
19 patients with benign breast disease; of
the carcinoma patients 25 were post-
operative, 4 had metastases and II had
receivedradiotherapy. This study does not
mention the hormonal status of the
patients and both patient groups and male
and female controls had similar cyto-
toxicities. Eremin et al. (1978) were
similarly unable to distinguish between
the cytotoxic capacity of 14 breast car-
cinoma patients and controls mea,sured
against the CLA-4 and Detroit 6 cell lines.
In this study 23 untreated patients with
early breast cancer showed a significant
reduction in NK activity directed towards
K562 target cells. The difference was
significant despite the wide range ofvalues
observed in the female control population,
itself a feature of NK measurements. In
adults NK activity is not affected by age
(Herberman & Holden, 1978) and there-
fore the age is unlikely to account for the
differences observed. This result is con-
firmed in Table II; subdividing the control
series into pre- and postmenopausal
groups (and consequently in terms of age)
did not produce a significant difference in
NK activity. Age and menopausal status
alone would therefore not appear to affect
the levels of cytotoxicity measured. Inter-
estingly women with benign breast dis-
ease, a group known to exhibit an
increased risk of breast carcinoma
(Hutchinson et al., 1980), showed levels of
NK activity which did not differ signifi-
cantly from those of controls. Cunning-
ham-Rundles et al. (1981) have observed
reduced NK activity to K562 in a group of
25 patients with benign breast disease, 23
of whom exhibited fibrocystic changes.
The group of benign patients studied in
this series contained almost equal numbers
with either fibrocystic or fibroadeno-
matous histopathology and this may
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account for the discrepancy in the two
reports.
There are several reports why our data
may conflict with previously published
results. The postoperative patients studied
by Eremin et al. (1978) and Cannon et al.
(1977) may have experienced a recovery of
cytotoxicity after the removal of the
tumour burden and the effect, of therapy
may also account for the discrepancy.
Further, variations in the target cells
employed may influence the level of
cytot,oxicity observed (Jondal et al., 1978).
In a more recent study Cunningham-
Rundles et al. (1981) were able to show
reduced peripheral-blood NK levels in a
group of 74 untreated women with malig-
nant breast, disease, results which are in
agreement with those presented in this
paper.
The observation that premenopausal
carcinoma patients differ most signifi-
cantly from controls with regard to NK
activity suggests that hormonal factors
may also influence NK levels in conjunc-
tion with malignancy. Further, whilst the
majority of carcinoma patients exhibited
irregular cycles, a well-reported observa-
tion (Grattarola, 1964), this cannot itself
account for the low NK activity observed,
as carcinoma patients with regular cycles
also showed depressed killing of K562.
Previous work on the effect of sex and
endocrine factors on cytotoxicity has been
contradictory. Baines et al. (1978) were
unable to demonstrate a significant effect
of either sex, age or stage in menstrual
cycle on the NK activity of normal
controls, though donors in the third
trimester of pregnancy did demonstrate
cytotoxicities significantly lower than
normal.
Experimental work in the mouse has
suggested that oestrogens may influence
NK levels (Seaman et al., 1978). Seaman et
al. (1979b) have shown that mouse oest-
radiol, which is itself non-toxic for NK
cells (Seaman et al., 1978, 1979a), may
suppress NK activity, perhaps via its
effect on the bone marrow, though doses of
oestradiol 9 times the physiological level
are required for 4-6 weeks before a decline
in activity is seen. Neonatal administra-
tion of diethyl stilboestrol also suppresses
NK activity (Kalland, 1980).
There is no clear evidence linking
hormones with cytotoxicity in humans
though steroid administration can lower
levels of killing (Herberman & Holden,
1978). Kovithavongs et al. (1974), how-
ever, suggested that endocrine factors may
influence antibody-dependent cell-
mediated cytotoxicity (ADCC) in healthy
individuals, an observation which may be
significant in the light of current sug-
gestions that ADCC and NK effectors
represent identical or overlapping popula-
tions (Johnsen & Madsen, 1980; Peter et
al., 1979). The control group presented in
this study, though smaller in number,
provides further evidence suggestive of a
hormonal effect on NK levels. NK effector
cells taken from controls in the second half
of their cycle show significantly greater
NK activity than those obtained from
donors in the first half. The imputed
cyclical variation was confirmed when cells
taken from one subject were tested
through a regular cycle (data not
presented).
In conclusion, this study demonstrates
that preoperative blood samples from
women with early breast carcinoma have
significantly reduced NK levels in com-
parison with a series of female controls.
This reduction is not apparent in women
with benign breast disease.
Changes in the level of significance in
pre- and postmenopausal carcinoma
patients and variation in the levels of NK
reactivity in controls in relation to men-
strual phase imply that endocrine factors
may also affect the level of NK activity
observed in conjunction with malignancy.
The latter observation, however, requires
further investigation.
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